Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Greggio

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Biochemical Society Transactions|September 20, 2012
Role of LRRK2 kinase activity in the pathogenesis of Parkinson's diseaseElisa Greggio
Essays in Biochemistry|December 13, 2021
LRRK2 signaling in neurodegeneration: two decades of progressLucia Iannotta, Elisa Greggio
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 14, 2017
PAKs in the brain: Function and dysfunctionLaura Civiero, Elisa Greggio
Expert Review of Proteomics|December 11, 2007
Kinase signaling pathways as potential targets in the treatment of Parkinson's diseaseElisa Greggio, Andrew Singleton
ASN Neuro|July 3, 2009
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questionsElisa Greggio, Mark R Cookson
Current Neuropharmacology|October 31, 2015
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?Jean-Marc Taymans, Elisa Greggio
Journal of Neurochemistry|June 29, 2021
Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for "Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo"Anna Masato, Luigi Bubacco, Elisa Greggio
Biochemical Society Transactions|February 17, 2017
Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?Elisa Greggio, Luigi Bubacco, Isabella Russo
American Journal of Neurodegenerative Disease|February 6, 2013
Exosomes-associated neurodegeneration and progression of Parkinson's diseaseIsabella Russo, Luigi Bubacco, Elisa Greggio
Biochemical Society Transactions|September 20, 2012
Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2Elisa Belluzzi, Elisa Greggio, Giovanni Piccoli
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Biochemical Society Transactions|September 20, 2012
Role of LRRK2 kinase activity in the pathogenesis of Parkinson's diseaseElisa Greggio
Essays in Biochemistry|December 13, 2021
LRRK2 signaling in neurodegeneration: two decades of progressLucia Iannotta, Elisa Greggio
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 14, 2017
PAKs in the brain: Function and dysfunctionLaura Civiero, Elisa Greggio
Expert Review of Proteomics|December 11, 2007
Kinase signaling pathways as potential targets in the treatment of Parkinson's diseaseElisa Greggio, Andrew Singleton
ASN Neuro|July 3, 2009
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questionsElisa Greggio, Mark R Cookson
Current Neuropharmacology|October 31, 2015
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?Jean-Marc Taymans, Elisa Greggio
Journal of Neurochemistry|June 29, 2021
Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for "Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo"Anna Masato, Luigi Bubacco, Elisa Greggio
Biochemical Society Transactions|February 17, 2017
Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?Elisa Greggio, Luigi Bubacco, Isabella Russo
American Journal of Neurodegenerative Disease|February 6, 2013
Exosomes-associated neurodegeneration and progression of Parkinson's diseaseIsabella Russo, Luigi Bubacco, Elisa Greggio
Biochemical Society Transactions|September 20, 2012
Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2Elisa Belluzzi, Elisa Greggio, Giovanni Piccoli
Pageof 10